title: Intravitreal pegaptanib for refractory macular edema secondary to retinal vein occlusion.
abstract: OBJECTIVE
  To assess the efficacy of intravitreal Pegaptanib sodium (Macugen(®)) injection in the management of refractory macular edema secondary to branch retinal vein occlusion.
  
  
  METHODS
  This is a prospective, nonrandomized, interventional case series. Five eyes of five patients with macular edema refractory to either bevacizumab or triamcinolone were treated with intravitreal injection of Pegaptanib sodium.
  
  
  RESULTS
  After three months follow-up, both visual acuity and macular edema, measured by optical coherence tomography and fluorescence angiography, dramatically improved.
  
  
  CONCLUSIONS
  Pegaptanib sodium is a safe and efficacy treatment for macular edema secondary to branch retinal vein occlusion.
authors.affiliation: Nuevo Hospital Universitario y Politecnico La Fe, Valencia, Spain. patyudaondo@hotmail.com
authors.forename: Patricia
authors.initials: P
authors.lastname: Udaondo
authors.forename: Salvador
authors.initials: S
authors.lastname: Garcia-Delpech
authors.forename: David
authors.initials: D
authors.lastname: Salom
authors.forename: Maria
authors.initials: M
authors.lastname: Garcia-Pous
authors.forename: Manuel
authors.initials: M
authors.lastname: Diaz-Llopis